Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.15 -1.92% 7.65 7.50 7.80 7.80 7.55 7.80 939,218 10:37:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.2 -2.1 - 21

Evgen Pharma Share Discussion Threads

Showing 8051 to 8071 of 8375 messages
Chat Pages: Latest  323  322  321  320  319  318  317  316  315  314  313  312  Older
DateSubjectAuthorDiscuss
06/4/2021
13:12
EVG was 14p not long ago.Crazy cheap entry and update due as well.imo
36jay
06/4/2021
12:34
Lol HH, in Huw we trust.:-)))
moneymunch
06/4/2021
12:26
5 baggers opportunity.Time to buy and hold.Next update will be massive.Dirt cheap entry.
36jay
06/4/2021
12:22
In MM we Trust!
hodhasharon
06/4/2021
11:42
christ, that didn’t take long 🤦🏼‍♂️🙄
bumpa33
06/4/2021
11:38
EVG EVG Mega deal inbound.Multi bagger opportunity.Dyor
36jay
06/4/2021
11:35
On the right side now, so its a wait and add as funds allow to become a multi bagger.
clocktower
06/4/2021
11:02
Hopefully so Rb, if it brings a few more onboard that can actually see the scale of the potential then all well and good. As for PR, I swear I’ve never met one who wasn’t cranially challenged to the ‘nth degree...
bumpa33
06/4/2021
10:57
Presumably today's volume is also a result of it being the first day of the new tax year, no more tax-loss selling, combined with investors buying to utilise thir new ISA allowance.
mesquida
06/4/2021
10:55
They don’t search the internet for sources of relevance or inspiration, more content to wait what is fed them by the hand that pays. Seems like your little gem of a find has got a few people thinking this morning.
riggerbeautz
06/4/2021
10:02
Thanks for the posts . Think I posted a few weeks ago and others maybe that Albena D-K is a special advisor to Evgen and is a prof at John Hopkins and the culman chempprotection offshoot . Looking forward to some movement again
peterm10
06/4/2021
09:42
I think that excellent find by bumpa33 could have brought in a few buyers. Really compelling read
muddy_40
06/4/2021
09:39
In a blink of an eye....;-)
moneymunch
06/4/2021
09:33
Back on the right road, hopefully soon be back in the blue.
clocktower
06/4/2021
07:58
Yep, and John Hopkins University research suggests and near enough validates that Sulforaphane is a promising treatment for Covid-19 and its variants, as well as ARDS and associated Respiratory disease, which has to increase the potent SFX-01's chances of success in treating Covid/ARDS.....the risk/reward now appears firmly in our favour.....let's see if the market has noticed while we await Prof Chalmers preliminary efficacy data from SFX-01's Covid/ARDS patient trials. Gla ;-) hTtps://www.biorxiv.org/content/10.1101/2021.03.25.437060v1.full
moneymunch
05/4/2021
18:46
It all helps Rb, you know how these things can go from ‘no one’ being interested to ‘everyone̵7; in the blink of an eye.
bumpa33
05/4/2021
14:54
Good to see doing your homework Bumpa, like that conclusion.
riggerbeautz
05/4/2021
13:46
More complelling data for SFX-01's chances of success. Gla ;-) 9/12/20 Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases Abstract COVID-19 is described in a clinical case involving a patient who proposed the hypothesis that Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-interacting nutrients may help to prevent severe COVID-19 symptoms. Capsules of broccoli seeds containing glucoraphanin were being taken before the onset of SARS-CoV-2 infection and were continued daily for over a month after the first COVID-19 symptoms. They were found to reduce many of the symptoms rapidly and for a duration of 6–12 h by repeated dosing. When the patient was stable but still suffering from cough and nasal obstruction when not taking the broccoli capsules, a double-blind induced cough challenge confirmed the speed of onset of the capsules (less than 10 min). A second clinical case with lower broccoli doses carried out during the cytokine storm confirmed the clinical benefits already observed. A third clinical case showed similar effects at the onset of symptoms. In the first clinical trial, we used a dose of under 600 μmol per day of glucoraphanin. However, such a high dose may induce pharmacologic effects that require careful examination before the performance of any study. It is likely that the fast onset of action is mediated through the TRPA1 channel. These experimental clinical cases represent a proof-of-concept confirming the hypothesis that Nrf2-interacting nutrients are effective in COVID-19. However, this cannot be used in practice before the availability of further safety data, and confirmation is necessary through proper trials on efficacy and safety. htTps://www.worldallergyorganizationjournal.org/article/S1939-4551(20)30401-4/fulltext
moneymunch
05/4/2021
12:18
That was a truly excellent article Bumpa. Thanks for sharing it!
bocker01
05/4/2021
12:04
Is there a correlation between the amount of mm posts and the steepness of our fallTry not to post mm ?
nico115
05/4/2021
08:54
“The similar results observed between the coronaviruses evaluated suggest that SFN could have broad activity against coronaviruses, a feature that may prove invaluable as new strains of pathogenic coronaviruses enter the human population.”
bumpa33
Chat Pages: Latest  323  322  321  320  319  318  317  316  315  314  313  312  Older
ADVFN Advertorial
Your Recent History
LSE
EVG
Evgen Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210513 04:05:40